Neisseria meningitidis is responsible for the seasonal burden and recurrent epidemics of
meningitis in an area of sub-Saharan Africa known as the meningitis belt. Historically, the …

For more than a century, meningitis epidemics have regularly recurred across sub-Saharan
Africa, involving 19 contiguous countries that constitute a 'meningitis belt'where historically …

In the African meningitis belt, the recurrent meningococcal meningitis epidemics are
generally caused by serogroup A. In the past 20 years, other serogroups have been …

Aim: The aim of this study was to assess changes in trends of meningococcal disease and
strain diversity of Neisseria meningitidis in Europe, South America, and Africa over the last …

Background The epidemiology of bacterial meningitis in the African 'meningitis belt'changes
periodically. In order to design an effective vaccination strategy, we have examined the …

Objective To undertake a review of the literature on the epidemiology of meningococcal
disease in India, with a view to informing future control policies. Methods We searched the …

Background The serogroup A conjugate meningococcal vaccine, MenAfriVac, was
introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and …

In the sub-Saharan African meningitis belt there is a region of hyperendemic and epidemic
meningitis stretching from Senegal to Ethiopia. The public health approaches to meningitis …

Serogroup X meningococci (Nm X) historically have caused sporadic and clustered
meningitis cases in sub-Saharan Africa. To study recent Nm X epidemiology, we analyzed …

The epidemiology of serogroup X meningococcal meningitis in Africa is unknown. During a
serogroup X meningococcus outbreak in Kenya, case finding involved record review at …